Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Penumbra Class I Recall Again Raises Concerns About 510(k) Pathway, Device Creep

Executive Summary

A case study of the Penumbra JET 7 class I recall in JAMA has again raised concerns about shortcomings in the US FDA’s 510(k) pathway in the medical community.

You may also be interested in...



US FDA Proposes Independent Contractor To Track User Fee Dollars Used To Pay FTEs

The agency published minutes from three MDUFA V user fee meetings with medtech industry. The talks include conversations about carryover funds and filling FTEs from past user fee deals.

FDA Official: Uptick In PMA, 510(k) Applications Calls For More User Fee Dollars

The number of PMA and 510(k) applications have been steadily growing and becoming harder to review as they’ve become more complex – which an FDA official says means the agency needs more financial resources.

Class I Recall On Penumbra Catheter After Death, Injury Reports

At least 14 stroke patient deaths have been linked to JET 7 catheters with Xtra Flex Technology since they were introduced last year.

Topics

UsernamePublicRestriction

Register

MT144823

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel